These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21593176)

  • 1. CD4+ T lymphocytes are critical mediators of tumor immunity to simian virus 40 large tumor antigen induced by vaccination with plasmid DNA.
    Aldrich JF; Lowe DB; Shearer MH; Winn RE; Jumper CA; Bright RK; Kennedy RC
    J Virol; 2011 Jul; 85(14):7216-24. PubMed ID: 21593176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of gamma interferon in DNA vaccine-induced tumor immunity targeting simian virus 40 large tumor antigen.
    Aldrich JF; Shearer MH; Lowe DB; Winn RE; Jumper CA; Kennedy RC; Bright RK
    Cancer Immunol Immunother; 2013 Feb; 62(2):371-82. PubMed ID: 22926061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro simian virus 40 large tumor antigen expression correlates with differential immune responses following DNA immunization.
    Lowe DB; Shearer MH; Tarbox JA; Kang HS; Jumper CA; Bright RK; Kennedy RC
    Virology; 2005 Feb; 332(1):28-37. PubMed ID: 15661138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+ T lymphocytes play a critical role in antibody production and tumor immunity against simian virus 40 large tumor antigen.
    Kennedy RC; Shearer MH; Watts AM; Bright RK
    Cancer Res; 2003 Mar; 63(5):1040-5. PubMed ID: 12615720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor immunity against a simian virus 40 oncoprotein requires CD8+ T lymphocytes in the effector immune phase.
    Lowe DB; Shearer MH; Jumper CA; Bright RK; Kennedy RC
    J Virol; 2010 Jan; 84(2):883-93. PubMed ID: 19889780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells.
    Utermöhlen O; Schulze-Garg C; Warnecke G; Gugel R; Löhler J; Deppert W
    J Virol; 2001 Nov; 75(22):10593-602. PubMed ID: 11602701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy of SV40 induced tumours in mice: a model for vaccine development.
    Bright RK; Shearer MH; Pass HI; Kennedy RC
    Dev Biol Stand; 1998; 94():341-53. PubMed ID: 9776255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective immunity in BALB/c mice against the simian virus 40-induced mKSA tumor resulting from injection of recombinant large T antigen. Requirement of CD8+ T lymphocytes.
    Zerrahn J; Utermöhlen O; Warnecke G; Deppert W; Lehmann-Grube F
    J Immunol; 1996 May; 156(10):3919-24. PubMed ID: 8621931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of simian virus 40 large T antigen recombinant protein and DNA immunization in the induction of protective immunity from experimental pulmonary metastasis.
    Watts AM; Shearer MH; Pass HI; Bright RK; Kennedy RC
    Cancer Immunol Immunother; 1999 Feb; 47(6):343-51. PubMed ID: 10203065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of tumor antigen-specific immunity in vivo by a novel vaccinia vector encoding safety-modified simian virus 40 T antigen.
    Xie YC; Hwang C; Overwijk W; Zeng Z; Eng MH; Mulé JJ; Imperiale MJ; Restifo NP; Sanda MG
    J Natl Cancer Inst; 1999 Jan; 91(2):169-75. PubMed ID: 9923859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine specificity of the murine immune response to SV40 large tumour antigen utilizing synthetic peptides that define selected epitopes.
    Bright RK; Shearer MH; Kennedy RC
    Clin Exp Immunol; 1994 Jun; 96(3):491-9. PubMed ID: 7516272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleic acid vaccination against virally induced tumors.
    Bright RK; Shearer MH; Kennedy RC
    Ann N Y Acad Sci; 1995 Nov; 772():241-51. PubMed ID: 8546399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of humoral immune responses and tumor immunity in mice immunized with recombinant SV40 large tumor antigen and a monoclonal anti-idiotype.
    Shearer MH; Bright RK; Kennedy RC
    Cancer Res; 1993 Dec; 53(23):5734-9. PubMed ID: 7694794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examination of lymphokines induced in mice following immunization with recombinant simian virus 40 large tumor antigen.
    Bright RK; Shearer MH; Kennedy RC
    Cancer Immunol Immunother; 1995 Mar; 40(3):206-11. PubMed ID: 7728780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies reacting to mimotopes of Simian virus 40 large T antigen, the viral oncoprotein, in sera from children.
    Mazzoni E; Frontini F; Rotondo JC; Zanotta N; Fioravanti A; Minelli F; Torreggiani E; Campisciano G; Marcuzzi A; Guerra G; Tommasini A; Touzé A; Martini F; Tognon M; Comar M
    J Cell Physiol; 2019 Apr; 234(4):3170-3179. PubMed ID: 30362540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmid DNA vaccines are effective in the absence of IFNgamma.
    Hassett DE; Zhang J; Whitton JL
    Virology; 1999 Oct; 263(1):175-83. PubMed ID: 10544092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization of mice with baculovirus-derived recombinant SV40 large tumour antigen induces protective tumour immunity to a lethal challenge with SV40-transformed cells.
    Shearer MH; Bright RK; Lanford RE; Kennedy RC
    Clin Exp Immunol; 1993 Feb; 91(2):266-71. PubMed ID: 7679059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of antibodies reacting to mimotopes of Simian virus 40 large T antigen, the oncoprotein, in serum samples of patients affected by non-Hodgkin lymphoma.
    Mazzoni E; Pietrobon S; Bilancia M; Vinante F; Rigo A; Ferrarini I; D'Agostino A; Casali MV; Martini F; Tognon M
    Cancer Immunol Immunother; 2017 Sep; 66(9):1189-1198. PubMed ID: 28455653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization of BALB/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells. An antibody-based mechanism for tumor immunity.
    Bright RK; Shearer MH; Kennedy RC
    J Immunol; 1994 Sep; 153(5):2064-71. PubMed ID: 8051411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free and viral chromosome-bound simian virus 40 T antigen: changes in reactivity of specific antigenic determinants during lytic infection.
    Tack LC; Wright JH; Gurney EG
    J Virol; 1986 May; 58(2):635-46. PubMed ID: 2422397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.